This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend Women's Health Professional Care

Legal Notice

BEST PRACTICE LONDON & WOMEN'S HEALTH PROFESSIONAL CARE EVENTS ARE SUPPORTED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. SESSIONS DELIVERED WITH INPUT FROM OUR SUPPORTERS WILL ALWAYS BE MARKED ON THE PROGRAMME.
A FULL LIST OF CONFIRMED SUPPORTERS FOR BEST PRACTICE LONDON CAN BE FOUND HERE.
A FULL LIST OF CONFIRMED SUPPORTERS FOR WOMEN'S HEALTH PROFESSIONAL CARE CAN BE FOUND HERE.

Co-Located Events

Exhibitor News

Subpage Hero

     

27 Jan 2025

Fertility Family Joins Women’s Health Professional Care Conference 2025

Health Medica Ltd Stand: WH-B40
Fertility Family Joins Women’s Health Professional Care Conference 2025

Watford, January 27, 2025 - Fertility Family, a leading provider of fertility supplements in the UK, has announced its participation in the upcoming Women’s Health Professional Care conference, taking place on the 26th and 27th of February at Olympia London.

 

The event, which is tailored for healthcare professionals and policymakers in primary and secondary care dedicated to enhancing health outcomes for women, brings together insights and fresh perspectives on a variety of issues impacting women throughout their lives. 

 

By addressing gender disparities in healthcare, the event aims to shine a spotlight on traditionally overlooked aspects of women’s health.

 

Fertility Family’s Role at Women’s Health Professional Care 2025

As a key participant, Fertility Family will deliver a symposium titled ‘PCOS: Optimising Metabolic and Reproductive Health in Women from adolescence to menopause’.

Polycystic Ovary Syndrome (PCOS) is a lifelong condition affecting women's metabolic, reproductive, and psychological health. This 30-minute symposium equips General Practitioners to effectively manage PCOS across life stages, from adolescence to menopause. Key areas include:

  • Early diagnosis to prevent long-term risks

  • Optimising fertility and pregnancy outcomes

  • Addressing cardiometabolic concerns during perimenopause

 

The symposium will run from 10:45 am to 11:15 am in The Contraceptive and Reproductive Health Theatre. This session provides evidence-based strategies and practical insights for holistic, age-appropriate care, improving immediate and long-term health outcomes for women with PCOS.

 

Meet the Speakers

Dr Priya Bhide, MD, PhD, FHEA, FRCOG

Priya Bhide is a Clinical Reader at Queen Mary University of London (QMUL). She is the module convener for Obstetrics and Gynaecology for undergraduate teaching at Bart’s and the London School of Medicine and Dentistry, QMUL.

She is an experienced clinician with more than a decade of experience in reproductive medicine and assisted conception and works as a member of the senior clinical team at the Homerton Fertility Centre, London. Priya’s research interests include primary research and evidence synthesis related to reproductive endocrinology, PCOS, subfertility and assisted conception. 

Ms Srividya Seshadri, MBBS, MD, FRCOG, MSC, FCRI 

Ms Seshadri is a Consultant Gynaecologist and an accredited subspecialist in reproductive medicine and surgery. Ms Seshadri’s dedication to advancing reproductive medicine is further evidenced by her role as an Honorary Associate Professor at UCL and her membership on the Executive Committee of the BFS.

Ms Seshadri completed her MD thesis on Reproductive Immunology at the University of Liverpool. She obtained her accreditation in Reproductive Medicine and Surgery at Guy’s and St Thomas NHS University Hospital in London. In addition, she obtained accreditation in Obstetrics and Gynaecology in London. 

 

Terry Sullivan, Managing Director at Fertility Family said: 

“We are pleased to be involved in this important educational event. It is a privilege to help facilitate delivery of key information to GPs and other Health Care Professionals that can make a dramatic difference to the lives of women from adolescence to post-menopause.” 

Ms Srividya Seshadri, Consultant Gynaecologist, said:

"Patient education, early diagnosis, and detection of PCOS enables optimisation of this metabolic condition and is crucial for improving the overall health and wellbeing of women."

Dr Priya Bhide, Clinical Reader at Queen Mary University of London, said: 

"Polycystic Ovary Syndrome (PCOS) is one of the most common yet underdiagnosed conditions affecting women, with implications that extend far beyond reproductive health. From increased risks of diabetes and cardiovascular disease to the emotional toll of infertility, PCOS impacts several aspects of a woman’s wellbeing. This symposium highlights the critical role GPs play in early diagnosis and tailored management, ensuring women receive the comprehensive care they need at every stage of life."

 

Join Fertility Family at Women’s Health Professional Care 2025

Registration for the event is now open! For more information, visit: https://www.womenshealthprofessionalcare.co.uk/

About Fertility Family 

Fertility Family is dedicated to providing information and products that help increase the chances of having a baby. Fertility Family was started by Pharmasure, which has been in the field of fertility for over 20 years and is partnered with Fertility Network UK and the British Fertility Society. Using their experience in the field, they have found carefully formulated products that have gone through clinical trials and are scientifically proven to help improve the chances of having a baby.

For further information please contact:

info@healthmedica.co.uk

View all Exhibitor News
Loading

Newsletter Sign Up